ATE386031T1 - Benzoylaminopyridylcarbonsäurederivate als glucokinaseaktivatoren - Google Patents

Benzoylaminopyridylcarbonsäurederivate als glucokinaseaktivatoren

Info

Publication number
ATE386031T1
ATE386031T1 AT04798661T AT04798661T ATE386031T1 AT E386031 T1 ATE386031 T1 AT E386031T1 AT 04798661 T AT04798661 T AT 04798661T AT 04798661 T AT04798661 T AT 04798661T AT E386031 T1 ATE386031 T1 AT E386031T1
Authority
AT
Austria
Prior art keywords
benzoylaminopyridyl
carboxylic acid
acid derivatives
glucokinase activators
methyl
Prior art date
Application number
AT04798661T
Other languages
English (en)
Inventor
Craig Johnstone
Darren Mckerrecher
Kurt Pike
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE386031T1 publication Critical patent/ATE386031T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Bidet-Like Cleaning Device And Other Flush Toilet Accessories (AREA)
  • External Artificial Organs (AREA)
  • Feeding And Guiding Record Carriers (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT04798661T 2003-11-29 2004-11-25 Benzoylaminopyridylcarbonsäurederivate als glucokinaseaktivatoren ATE386031T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0327760.5A GB0327760D0 (en) 2003-11-29 2003-11-29 Compounds

Publications (1)

Publication Number Publication Date
ATE386031T1 true ATE386031T1 (de) 2008-03-15

Family

ID=29798044

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04798661T ATE386031T1 (de) 2003-11-29 2004-11-25 Benzoylaminopyridylcarbonsäurederivate als glucokinaseaktivatoren

Country Status (9)

Country Link
US (1) US20090018157A1 (de)
EP (1) EP1689741B1 (de)
JP (1) JP2007512300A (de)
CN (1) CN1886401A (de)
AT (1) ATE386031T1 (de)
DE (1) DE602004011814T2 (de)
ES (1) ES2299886T3 (de)
GB (1) GB0327760D0 (de)
WO (1) WO2005054233A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0102299D0 (sv) 2001-06-26 2001-06-26 Astrazeneca Ab Compounds
SE0102764D0 (sv) 2001-08-17 2001-08-17 Astrazeneca Ab Compounds
GB0226930D0 (en) 2002-11-19 2002-12-24 Astrazeneca Ab Chemical compounds
GB0226931D0 (en) 2002-11-19 2002-12-24 Astrazeneca Ab Chemical compounds
BRPI0507746A (pt) * 2004-02-18 2007-07-10 Astrazeneca Ab composto ou um sal, pró-droga ou solvato do mesmo, composição farmacêutica, método de tratar doenças mediadas por glk, e, processo para a preparação de um composto
TW200600086A (en) * 2004-06-05 2006-01-01 Astrazeneca Ab Chemical compound
TW200714597A (en) * 2005-05-27 2007-04-16 Astrazeneca Ab Chemical compounds
JP2009500442A (ja) * 2005-07-09 2009-01-08 アストラゼネカ アクチボラグ ２型糖尿病を処置するためのグルコキナーゼのモジュレーターとしての２−ヘテロシクリルオキシベンゾイルアミノヘテロシクリル化合物
KR101346902B1 (ko) 2005-07-09 2014-01-02 아스트라제네카 아베 당뇨병 치료에 있어 ｇｌｋ 활성화제로서 사용하기 위한헤테로아릴 벤즈아미드 유도체
JP2007063225A (ja) 2005-09-01 2007-03-15 Takeda Chem Ind Ltd イミダゾピリジン化合物
CA2624102A1 (en) 2005-09-29 2007-04-12 Sanofi-Aventis Phenyl- and pyridinyl- 1, 2 , 4 - oxadiazolone derivatives, processes for their preparation and their use as pharmaceuticals
EP2001875A2 (de) 2006-03-08 2008-12-17 Takeda San Diego, Inc. Glucokinase-aktivatoren
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
EP2049518B1 (de) 2006-05-31 2011-08-31 Takeda San Diego, Inc. Indazol- und isoindolderivate als glucokinaseaktivierende stoffe
TW200825060A (en) * 2006-10-26 2008-06-16 Astrazeneca Ab Chemical compounds
US8163779B2 (en) 2006-12-20 2012-04-24 Takeda San Diego, Inc. Glucokinase activators
US8173645B2 (en) 2007-03-21 2012-05-08 Takeda San Diego, Inc. Glucokinase activators
EP2324028A2 (de) 2008-08-04 2011-05-25 AstraZeneca AB Therapeutische mittel 414
GB0902434D0 (en) * 2009-02-13 2009-04-01 Astrazeneca Ab Chemical process
GB0902406D0 (en) * 2009-02-13 2009-04-01 Astrazeneca Ab Crystalline polymorphic form
AR076221A1 (es) * 2009-04-09 2011-05-26 Astrazeneca Ab Derivado de pirazol [4,5-e] pirimidina y su uso para tratar diabetes y obesidad
WO2010116177A1 (en) 2009-04-09 2010-10-14 Astrazeneca Ab A pyrazolo [4,5-e] pyrimidine derivative and its use to treat diabetes and obesity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0102300D0 (sv) * 2001-06-26 2001-06-26 Astrazeneca Ab Compounds

Also Published As

Publication number Publication date
EP1689741B1 (de) 2008-02-13
EP1689741A1 (de) 2006-08-16
JP2007512300A (ja) 2007-05-17
HK1092803A1 (en) 2007-02-16
DE602004011814D1 (en) 2008-03-27
CN1886401A (zh) 2006-12-27
ES2299886T3 (es) 2008-06-01
WO2005054233A1 (en) 2005-06-16
GB0327760D0 (en) 2003-12-31
DE602004011814T2 (de) 2009-02-05
US20090018157A1 (en) 2009-01-15

Similar Documents

Publication Publication Date Title
ATE386031T1 (de) Benzoylaminopyridylcarbonsäurederivate als glucokinaseaktivatoren
TW200602028A (en) Compounds
NO20062269L (no) Pyridin-karboksylsyrederivater som glucokinasemodulatorer
TW200604186A (en) Compounds
TW200600086A (en) Chemical compound
DE60215814D1 (de) Vinylphenyl-derivate als glk-aktivatoren
ATE506354T1 (de) Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren
DE60226469D1 (de) Biphenylkarbonsäureamidderivate als p38 kinase-inhibitoren
DE602004008098D1 (de) Substituierte 2h-ä1,2,4ütriazoloä4,3-aüpyrazine als gsk-3-inhibitoren
MEP51408A (en) Selected cgrp antagonists, method for production and use thereof as medicament
NO20075169L (no) Nye imidazo (1,5-A)pyndindenvater, fremgangsmate for fremstilling og farmasoytiske sammensetninger som inneholder samme.
EA200301306A1 (ru) Производные 1-фенилсульфонил-1,3-дигидро-2h-индол-2-она, их получение и их терапевтическое применение
NO20053794L (no) N-(1-benzyl-2-oxo-2-(1-piperazinyl) etyl)-1-piperidinkarboksamid-derivater og relaterte forbindelsers bruk som CGRP-antagonister for behandling av hodepine.
MXPA05011710A (es) Derivados de pirimidina con actividad de crf.
NO20052496L (no) Selekterte CGRP antagonister, fremgangsmater for fremstilling derav og anvendelse derav som medikamenter.
MXPA05011411A (es) 1,4-diazepinas sustituidas y usos de las mismas.
NO20050418L (no) Kondenserte pyridiner og pyrimidiner med TIE2(TEK) aktivitet
NO20070173L (no) Nye forbindelser
SE0403171D0 (sv) New compounds
SG171471A1 (en) New benzimidazole derivatives
DE60212959D1 (de) Eine sulfonimid-gruppe enthaltende oxazolidinone als antibiotika
ATE505462T1 (de) Neue biologischaktive molekü le
NO20070157L (no) Substituerte diketopiperaziner som oksytocinantagonister
HRP20070529T3 (hr) Derivati imidazola kao antagonisti receptora glutamata
EP2000473A4 (de) Trehaloseverbindung und arzneimittel mit der verbindung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties